Michael, Samuel
- National Center for Advancing Translational Sciences (no department on record)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #120
- Top 1% Funded
- Rising Star
- Sustained Excellence
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2017 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
NIH Funding · FY2023
Linked Award Amount
$15.1M
Full award amounts, FY2023
Award Records
3
Records listing this PI
Award-Linked Rank
#120
By linked amount among FY2023 PIs
Earliest Year Loaded
2017
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Michael, Samuel as a PI. Multi-PI records show the full award amount for context.
- 1ZICTR000438-02ZICContact PIDevelopment of A Specialized Platform for Innovative Research Exploration (ASPIRE)$6.4Maward amount
- 1ZICTR000242-09ZICContact PIResearch Services Core (RSC)$4.7Maward amount
- 1ZIATR000344-06ZIAContact PIHelping to End Addiction Long-term (HEAL): New Chemical Structures for Pain, Addiction and Overdose Targets$4Maward amount
Award organization
Organizations that administered FY2023 awards listing Michael, Samuel as a PI.
FY2023 award administered by National Center for Advancing Translational Sciences ().
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2017First NIH AwardNational Center for Advancing Translational Sciences
- 2017$500K Cumulative Funding
- 2017$1M Cumulative Funding
- 2017$2M Cumulative Funding
- 2017Entered Top 50% NationallyRanked #1798
- 2017Entered Top 25% NationallyRanked #1798
- 2017Entered Top 10% NationallyRanked #1798
- 2018$5M Cumulative Funding
- 2018Entered Top 5% NationallyRanked #274
- 2019$10M Cumulative Funding
- 2019Entered Top 1% NationallyRanked #102
- 2021$25M Cumulative Funding
- 2022$50M Cumulative Funding